Uranusweg 3 8938 AJ Leeuwarden The Netherlands +31(0) 58 216 75 99 info@fiber-line.com ABOUT FIBER-LINE® NOTICE: The information and data contained herein do not constitute sales specifications.

Avient has compiled extensive data that enabled the OEM to shave weeks off the product development timeline and save nearly $50,000 in potential antimicrobial product protection testing fees.

This certification ensures that our tool meets rigorous criteria and addresses relevant safety aspects, providing you with reliable and accurate data.

Technical Data Sheets Safety Data Sheets Technical Data Sheets

Technical Data Sheets Safety Data Sheets Technical Data Sheets

Technical Data Sheets Safety Data Sheets Technical Data Sheets

Technical Data Sheets Safety Data Sheets Technical Data Sheets

Technical Data Sheets Safety Data Sheets Technical Data Sheets

Technical Data Sheets Safety Data Sheets Technical Data Sheets

EPS: $1.20 Proforma Debt Maturities & Liquidity Summary – 12/31/12 (Reflecting Financing & Spartech Acquisition) • Total Debt at 12/31/12 h $1,010 $297 $360 $300 $400 Debt Maturities As of December 31, 2012 ($ millions) Less: Cash Net Debt 213 $797 $50 $297 $100 $200 • Available Liquidity Cash $213 $800 Debt Maturities As of December 31, 2012 P f f 2/13 Fi i $50 $0 2015 2017 2020 Interest Rates: 7.500% 5.000% 7.375% Cash ABL Availability Total Liquidity $213 271 $484 $600 $400 $600 Proforma for 2/13 Financing ($ millions) Total Liquidity • Net Debt / EBITDA = 2.0x* $484 $50 $360 $0 $200 • Net Debt / EBITDA = 2.35x** $50$0 2015 2020 2023 Page 14 Interest Rates: 7.500% 7.375% 5.250% *Assumes $65 million of synergies related to Spartech acquistion **Assumes no synergies related to Spartech acquistion Use of Cash Share DividendsOrganic G Acquisitions • Repurchased 1 2 Repurchase • Introduced a Dividends • Expanding our Growth T t th t d Acquisitions • Repurchased 1.2 million shares in 2012 • 20.0 million shares are il bl f • Introduced a quarterly dividend in Q1 2011 and increased in Q1 2012 (25%) and Q1 2013 (20%) • Expanding our sales, marketing, and technical capabilities is top priority • Investing in • Targets that expand our: • Specialty offering • End market presence • Geographic footprint available for repurchase under the current authorization Q1 2013 (20%) • Objective of maintaining and growing Investing in operational and LSS initiatives (including synergy capture) • CAPEX • Synergy opportunities • Adjacent material solutions Proforma Cash Balance = $213M N t D bt / EBITDA* 2 0X CAPEX Net Debt / EBITDA* = 2.0X *Adjusted EBITDA assumes synergies related to the Spartech acquisition are realized at close; preliminary synergies estimated at $65M and are expected to be achieved over a 3-year period Page 15 Why Invest In PolyOne? Strong past performance demonstrates that our strategy and execution are workinggy g • Megatrends align with our strengths • Innovation and services provide differentiation and competitive advantage • Strong and proven management team driving growth and performancegrowth and performance The New PolyOne: A Specialty Growth Company $2015 Target: $2.50 Adjusted EPS Page 16 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S.